AEGON ASSET MANAGEMENT UK Plc grew its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 3.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,068,357 shares of the company's stock after acquiring an additional 31,897 shares during the quarter. Colgate-Palmolive accounts for 1.5% of AEGON ASSET MANAGEMENT UK Plc's portfolio, making the stock its 15th largest holding. AEGON ASSET MANAGEMENT UK Plc owned approximately 0.13% of Colgate-Palmolive worth $100,006,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in CL. Sentry Investment Management LLC increased its position in Colgate-Palmolive by 7.1% during the 1st quarter. Sentry Investment Management LLC now owns 2,533 shares of the company's stock worth $226,000 after buying an additional 168 shares during the period. RFG Advisory LLC boosted its holdings in Colgate-Palmolive by 85.6% during the 1st quarter. RFG Advisory LLC now owns 9,104 shares of the company's stock valued at $853,000 after acquiring an additional 4,199 shares during the period. Capital Asset Advisory Services LLC increased its position in Colgate-Palmolive by 60.5% during the 1st quarter. Capital Asset Advisory Services LLC now owns 23,518 shares of the company's stock valued at $2,200,000 after buying an additional 8,869 shares in the last quarter. Merit Financial Group LLC increased its holdings in shares of Colgate-Palmolive by 13.6% in the first quarter. Merit Financial Group LLC now owns 34,809 shares of the company's stock worth $3,262,000 after purchasing an additional 4,169 shares during the last quarter. Finally, Baxter Bros Inc. boosted its holdings in shares of Colgate-Palmolive by 2.6% in the first quarter. Baxter Bros Inc. now owns 19,273 shares of the company's stock valued at $1,806,000 after purchasing an additional 480 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Price Performance
NYSE CL traded down $0.16 on Thursday, hitting $90.04. 5,106,833 shares of the company's stock were exchanged, compared to its average volume of 4,701,832. The stock has a 50-day moving average of $91.92 and a 200-day moving average of $91.25. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The stock has a market cap of $72.97 billion, a price-to-earnings ratio of 25.58, a P/E/G ratio of 4.20 and a beta of 0.39.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The business had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same period in the prior year, the business posted $0.86 earnings per share. Colgate-Palmolive's quarterly revenue was down 3.0% on a year-over-year basis. Analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive declared that its Board of Directors has approved a stock repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.31%. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive's payout ratio is currently 58.76%.
Analyst Ratings Changes
Several analysts recently weighed in on CL shares. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Wells Fargo & Company raised their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Barclays dropped their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research report on Friday, April 11th. Finally, Citigroup lifted their price target on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $102.12.
View Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.